Immunological Response to COVID-19 Vaccine Boosters in Multiple Sclerosis Patients Treated with anti-CD20 Therapy

被引：0
|
作者：
De Oliveira, Antonia [1 ]
Lei, Joyce [1 ]
Liu, Jiayuan [1 ]
Roche, Morgan [1 ]
Lin, Jerry [1 ]
Alfonso, Roberto [2 ]
Sadiq, Saud [1 ]
机构：
[1] Tisch Multiple Sclerosis Res Ctr New York, New York, NY USA
[2] Tisch Multiple Sclerosis, New York, NY USA
来源：
NEUROLOGY | 2023年 / 100卷 / 17期
关键词：
D O I：
10.1212/WNL.0000000000202245
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
S21.001
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Vertebral Inflammatory Changes in Multiple Sclerosis Patients Treated with Anti-CD20 Drugs
    Kilgo, W. A.
    Minto, E.
    Soltys, J.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 103 - 103
  • [22] Multiple Sclerosis and disability progression in anti-CD20 treated patients: a radiomics approach
    Panzera, Ivan
    Fiscone, Cristiana
    Tonon, Caterina
    Lugaresi, Alessandra
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 561 - 561
  • [23] Booster Dose of mRNA-Based COVID-19 Vaccine Induces a Humoral and Cellular Response in Patients Recently Treated with Anti-CD20 Monoclonal Antibodies
    Nishikubo, Masashi
    Shimomura, Yoshimitsu
    Yamamoto, Ryusuke
    Maruoka, Hayato
    Nasu, Seiko
    Nishioka, Tomomi
    Sakizono, Kenji
    Mitsuyuki, Satoshi
    Kubo, Tomoyo
    Okada, Naoki
    Nakagawa, Daishi
    Kamijo, Kimimori
    Imoto, Hiroharu
    Nagai, Yuya
    Hiramoto, Nobuhiro
    Yoshioka, Satoshi
    Yonetani, Noboru
    Kondo, Tadakazu
    Ishikawa, Takayuki
    BLOOD, 2022, 140 : 2633 - 2634
  • [24] Outcomes in Patients with Hematological Malignancies Receiving Anti-CD20 Therapy in the Setting of COVID-19 Infection
    Lopez, Carlos A.
    Chitty, David
    Chi, Jeffrey
    Saif, Wasif
    Goldberg, Bradley
    BLOOD, 2020, 136
  • [25] Association Between Anti-CD20 Therapies and COVID-19 Severity Among Patients With Relapsing-Remitting and Progressive Multiple Sclerosis
    Januel, Edouard
    Hajage, David
    Labauge, Pierre
    Maillart, Elisabeth
    De Seze, Jerome
    Zephir, Helene
    Pelletier, Jean
    Guilloton, Laurent
    Bensa, Caroline
    Heinzlef, Olivier
    Casez, Olivier
    Biotti, Damien
    Bourre, Bertrand
    Vukusic, Sandra
    Maurousset, Aude
    Berger, Eric
    Laplaud, David
    Lebrun-Frenay, Christine
    Dubessy, Anne-Laure
    Branger, Pierre
    Thouvenot, Eric
    Clavelou, Pierre
    Sellal, Francois
    Manchon, Eric
    Moreau, Thibault
    Papeix, Caroline
    Tubach, Florence
    Louapre, Celine
    JAMA NETWORK OPEN, 2023, 6 (06) : E2319766
  • [26] Learning multiple sclerosis immunopathogenesis from anti-CD20 therapy
    Heming, Michael
    Wiendl, Heinz
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2023, 120 (06)
  • [27] Humoral vaccine response and COVID-19 hospitalizations in vaccinated multiple sclerosis patients treated with rituximab
    Torgauten, H.
    Onyangp, T.
    Hallin, E.
    Serkland, T.
    Skrede, S.
    Cox, R.
    Langeland, N.
    Myhr, K.
    Torkildsen, O.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 736 - 736
  • [28] COVID-19 mRNA Vaccine in Patients With Lymphoid Malignancy or Anti-CD20 Antibody Therapy: A Systematic Review and Meta-Analysis
    Ito, Yusuke
    Honda, Akira
    Kurokawa, Mineo
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (08): : E691 - E707
  • [29] Risk factors for developing lymphopenia and hypogammaglobulinemia in anti-cd20 treated patients with multiple sclerosis
    Vollmer, B.
    Vollmer, T.
    Corboy, J.
    Alvarez, E.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 304 - 304
  • [30] COVID-19 in patients with chronic lymphocytic leukemia treated with venetoclax: what is the role of anti-CD20 antibody?
    Autore, Francesco
    Visentin, Andrea
    Deodato, Marina
    Vitale, Candida
    Galli, Eugenio
    Fresa, Alberto
    Fazzi, Rita
    Sanna, Alessandro
    Olivieri, Jacopo
    Scortechini, Ilaria
    Principe, Maria Ilaria Del
    Sportoletti, Paolo
    Innocenti, Idanna
    Coscia, Marta
    Tedeschi, Alessandra
    Trentin, Livio
    Candoni, Anna
    Busca, Alessandro
    Pagano, Livio
    Laurenti, Luca
    BLOOD ADVANCES, 2025, 9 (01) : 162 - 165
12345